127 related articles for article (PubMed ID: 26159783)
1. MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β.
Wang Y; Feng J; Zang W; Du Y; Chen X; Sun Q; Dong Z; Zhao G
Cell Physiol Biochem; 2015; 36(4):1587-96. PubMed ID: 26159783
[TBL] [Abstract][Full Text] [Related]
2. G648C variant of DNA polymerase β sensitizes esophageal cancer to chemotherapy.
Wang Y; Sun Q; Guo W; Chen X; Du Y; Zang W; Dong Z; Zhao G
Tumour Biol; 2016 Feb; 37(2):1941-7. PubMed ID: 26334617
[TBL] [Abstract][Full Text] [Related]
3. MiR-149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase β.
Wang Y; Chen J; Zhang M; Zhang W; Li M; Zang W; Dong Z; Zhao G
J Cell Mol Med; 2018 Aug; 22(8):3857-3865. PubMed ID: 29726631
[TBL] [Abstract][Full Text] [Related]
4. Roles of GST-π and polβ genes in chemoresistance of esophageal carcinoma cells.
Tang Y; Xuan XY; Li M; Dong ZM
Asian Pac J Cancer Prev; 2013; 14(12):7375-9. PubMed ID: 24460306
[TBL] [Abstract][Full Text] [Related]
5. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
Wu K; Yang Y; Zhao J; Zhao S
Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
[TBL] [Abstract][Full Text] [Related]
6. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.
Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273
[TBL] [Abstract][Full Text] [Related]
7. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
8. MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.
Li Z; Li S; Wen Y; Chen J; Liu K; Jia J
Technol Cancer Res Treat; 2021; 20():15330338211039127. PubMed ID: 34747666
[No Abstract] [Full Text] [Related]
9. Enhancement of silencing DNA polymerase β on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines.
Wang Y; Chen X; Hu X; Zhang R; Du Y; Zang W; Dong Z; Zhao G
Tumour Biol; 2014 Oct; 35(10):10067-74. PubMed ID: 25015190
[TBL] [Abstract][Full Text] [Related]
10. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
Chen Q; Hou J; Wu Z; Zhao J; Ma D
Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
12. α-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA‑138 expression.
Wu J; Wang L; Du X; Sun Q; Wang Y; Li M; Zang W; Liu K; Zhao G
Oncol Rep; 2018 Mar; 39(3):1163-1172. PubMed ID: 29328459
[TBL] [Abstract][Full Text] [Related]
13. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM
Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced modification of microRNA expression in esophageal cancer.
Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
[TBL] [Abstract][Full Text] [Related]
17. Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells.
Shi S; Huang X; Ma X; Zhu X; Zhang Q
PLoS One; 2020; 15(5):e0225290. PubMed ID: 32369495
[TBL] [Abstract][Full Text] [Related]
18. DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment.
Wang T; Zang W; Ma Y; Li M; Xuan X; Wang N; Wu R; Li Y; Dong Z; Zhao G
Mol Biol Rep; 2013 Feb; 40(2):1333-9. PubMed ID: 23117284
[TBL] [Abstract][Full Text] [Related]
19. Increased Nanog expression promotes tumor development and Cisplatin resistance in human esophageal cancer cells.
Yang L; Zhang X; Zhang M; Zhang J; Sheng Y; Sun X; Chen Q; Wang LX
Cell Physiol Biochem; 2012; 30(4):943-52. PubMed ID: 23221432
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR‑106b‑3p increases sensitivity to cisplatin in esophageal cancer cells by targeting TGM3.
Zhu Y; Zhang Y; Li X; Su Y; Wang N; Chen M; Yang Z
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33899115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
